|
Match
|
Document |
Document Title |
|
|
EP1844785A1 |
Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability
The present invention relates to novel phospholipids complexes of olive fruits or leaves extracts or compositions containing it having improved bioavailability.
|
|
|
EP1837030A1 |
Phospholipid complexes of curcumin having improved bioavailability
The present invention relates to novel phospholipids complexes of curcumin or extracts containing it having improved bioavailability.
|
|
|
EP1663267B1 |
ORAL COMPOSITIONS FOR THE TREATMENT OF CELLULITE
Abstract not available for EP1663267
|
|
|
EP1559430A1 |
Use of ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue
The invention is directed to the use of Ginkgo complexed with phosphatidylserine for the manufacture of a medicament or a dietary supplement for the enhancement of cognitive function and mental...
|
|
|
EP0691852B1 |
VALPROIC ACID COVALENTLY BONDED TO A LYSOPHOSPHOLIPID
Abstract not available for EP0691852 Abstract of corresponding document: WO9422483 The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a...
|
|
|
EP1245230A2 |
Amentoflavone as an antiviral agent
Substantially purified antiviral biflavanoids robustaflavone, hinokiflavone, amentoflavone, agathisflavone, volkensiflavone, morelloflavone, rhusflavanone, succedaneaflavanone, GB-1a and GB-2a are...
|
|
|
6413949 |
Prodrugs with enhanced penetration into cells
The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a pharmacologically active compound and an intracellular transporting adjuvant, characterized by the...
|
|
|
6313106 |
Phospholipid derivatives of valproic acid and mixtures thereof
The present invention relates to compounds, which are phospholipid derivatives of valproic acid, to compositions comprising said compounds and their use for treating epilepsy, migraine, bipolar...
|
|
|
EP0711560B1 |
Pharmaceutical composition for the oral administration of flavonoids
Abstract of EP0711560 Oral compsns. contain a rutaceous flavonoid, partic. micronised diosmin (I), as an effervescent granulate in the form of tablets or sachets. The compsn. pref. comprises 0.1-5...
|
|
|
6166089 |
Prodrugs with enhanced penetration into cells
The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a pharmacologically active compound and an intracellular transporting adjuvant, characterized by the...
|
|
|
6136796 |
Prodrugs with enhanced penetration into cells
The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a pharmacologically active compound and an intracellular transporting adjuvant, characterized by the...
|
|
|
6077837 |
Prodrugs with enhanced penetration into cells
The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a pharmacologically active compound and an intracellular transporting adjuvant, characterized by the...
|
|
|
EP0573260B1 |
New alkaloid derivatives, their use and pharmaceutical formulations containing them
Abstract of EP0573260 Salts of a pharmacologically active, naturally occurring or synthetic alkaloids, or alkaloid derivatives and a phosphatidic acid are provided, which preferably have the...
|
|
|
5985854 |
Prodrugs with enhanced penetration into cells
The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a pharmacologically active compound and an intracellular transporting adjuvant, characterized by the...
|
|
|
5958104 |
Methods and compositions for enhancing plant growth
The present invention provides methods for treating plants, and for enhancing the growth of plants. The methods include applying an alkyl glucoside compound to the plant. The present invention also...
|
|
|
EP0627909B1 |
COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF A POLYPHENOL AND A GINKGO EXTRACT
Abstract not available for EP0627909 Abstract of corresponding document: US5686082 PCT No. PCT/FR93/01295 Sec. 371 Date Oct. 19, 1994 Sec. 102(e) Date Oct. 19, 1994 PCT Filed Dec. 23, 1993 PCT...
|
|
|
5686082 |
Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract
A cosmetic or pharmaceutical composition containing a synergistically active oxidation inhibiting system consisting of a combination of a ginkgo extract and at least one polyphenol compound. For...
|
|
|
5587171 |
Cosmetic of dermopharmaceutical composition containing, in combination, a lauroylmethionate of a basic amino acid and at least one polyphenol
Cosmetic or dermopharmaceutical composition. This composition is characterized in that it contains, in a suitable vehicle, an antioxidizing system possessing a synergic effect consisting of the...
|
|
|
EP0541874B1 |
Compositions containing diosmin
Abstract of EP0541874 The subject of the invention is new pharmaceutical compositions intended for the digestive tract, whose active ingredient is a flavonoid glycoside. It relates to pulverulent...
|
|
|
EP0595694B1 |
Cosmetic or dermopharmaceutical composition containing in association a lauroylmethionate of a basic aminoacid and at least a polyphenol
Abstract of EP0595694 Cosmetic or dermopharmaceutic composition. This composition is characterised in that it contains, in a suitable vehicle, an antioxidising system of synergistic action...
|
|
|
EP0711560A1 |
Pharmaceutical composition for the oral administration of flavonoids
Oral compsns. contain a rutaceous flavonoid, partic. micronised diosmin (I), as an effervescent granulate in the form of tablets or sachets. The compsn. pref. comprises 0.1-5 g (I) which is pref....
|
|
|
EP0691852A1 |
VALPROIC ACID COVALENTLY BONDED TO A LYSOPHOSPHOLIPID
Abstract not available for EP0691852 Abstract of corresponding document: WO9422483 The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a...
|
|
|
5431912 |
Cosmetic or dermopharmaceutical composition containing, in combination, a lauroylmethionate of a basic amino acid and at least one polyphenol
The present invention addresses a cosmetic or dermopharmaceutical composition comprising, in a suitable vehicle, an antioxidizing system possessing a synergic effect consisting of the combination...
|
|
|
EP0464297B1 |
Complexes of neolignane derivatives with phospholipids, the use thereof and pharmaceutical and cosmetic formulations containing them
Abstract of EP0464297 Complexes of lipophilic extracts from plants of Krameria or Eupomatia genus and of some neolignanes isolated from the same extracts with natural or synthetic phospholipids;...
|
|
|
EP0441279B1 |
Bilobalide phospholipide complexes, their applications and formulations containing them
Abstract of EP0441279 Complexes between natural or synthetic phospholipids and bilobalide, a sesquiterpene extracted from the leaves of Gingko biloba, are disclosed, as well as the preparation...
|
|
|
EP0595694A1 |
Cosmetic or dermopharmaceutical composition containing in association a lauroylmethionate of a basic aminoacid and at least a polyphenol.
Cosmetic or dermopharmaceutic composition. This composition is characterised in that it contains, in a suitable vehicle, an antioxidising system of synergistic action consisting of the combination...
|
|
|
EP0573260A1 |
New alkaloid derivatives, their use and pharmaceutical formulations containing them.
Salts of a pharmacologically active, naturally occurring or synthetic alkaloids, or alkaloid derivatives and a phosphatidic acid are provided, which preferably have the formula wherein Alk ...
|
|
|
EP0275224B1 |
Phospholipidic complexes of vitis vinifera extracts, process for their preparation and pharmaceutical and cosmetic compositions containing them
Abstract not available for EP0275224 Abstract of corresponding document: US4963527 Complexes resulting from the reaction of phospholipids, synthetic or of vegetable or animal origin, with...
|
|
|
EP0541874A1 |
Compositions containing diosmin.
The subject of the invention is new pharmaceutical compositions intended for the digestive tract, whose active ingredient is a flavonoid glycoside. It relates to pulverulent preparations intended...
|
|
|
5202313 |
Bilobalide derivatives, their applications and formulations containing them
Complexes between natural or synthetic phospholipids and bilobalide, a sesquiterpene extracted from the leaves of Gingko biloba, are disclosed, as well as the preparation thereof and their...
|
|
|
EP0464297A1 |
Complexes of neolignane derivatives with phospholipids, the use thereof and pharmaceutical and cosmetic formulations containing them.
Complexes of lipophilic extracts from plants of Krameria or Eupomatia genus and of some neolignanes isolated from the same extracts with natural or synthetic phospholipids; said complexes proved to...
|
|
|
EP0441279A1 |
Bilobalide phospholipide complexes, their applications and formulations containing them.
Complexes between natural or synthetic phospholipids and bilobalide, a sesquiterpene extracted from the leaves of Gingko biloba, are disclosed, as well as the preparation thereof and their...
|
|
|
EP0275224A2 |
Phospholipidic complexes of vitis vinifera extracts, process for their preparation and pharmaceutical and cosmetic compositions containing them.
Abstract not available for EP0275224 Abstract of corresponding document: US4963527 Complexes resulting from the reaction of phospholipids, synthetic or of vegetable or animal origin, with...
|